Tab Title Description
This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria1. Male2. >18 years old3. Candidate for TULSA-PRO treatment4. willing and able to sign the Informed Consent formExclusion Criteria:None.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 01/20/2026. Questions regarding updates should be directed to the study team contact.
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
Mayo Clinic principal investigator
David Woodrum, M.D., Ph.D.
Contact us for the latest status
Desirae Howe-Clayton
5072550111
Contact Ushowe.desirae@mayo.edu